Diuretics Flashcards

0
Q

Furosemide Adverse Effects

A
Loop, NKCC2
**Ototoxicity**
Hyperuricemia
Acute Hypovolemia
**Hypokalemia**
Hypomagnesemia
Allergies (Sulfa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Furosemide Indications

A

Loop
NKCC2
DOC for acute pulmonary edema with heart failure
Hypercalcemia
Hyperkalemia
Ethacrynic acid is non-sulfa but more ototoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Torsemide indications

A

Loop, NKCC2
DOC for acute pulmonary edema with heart failure
Hypercalcemia
Hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Torsemide adverse effects

A
Loop, NKCC2
**Ototoxicity**
Hyperuricemia
Acute hypovolemia
**Hypokalemia**
Hypomagnesemia
Allergies (sulfa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Loop Diuretics Mechanism

A

NKCC2
Site-ascending LOH
Blocks Na/Cl/K co transporter
Increased prostaglandin synthesis (COX2)
Ethacrynic acid is non sulfa but more ototoxic, furosemide and torsemide are sulfa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Loop Diuretic Urine Composition

A

Increased calcium, sodium, potassium, magnesium

Increased volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Thiazides Mechanism

A

NCCT
Site - DCT
Block Na/Cl co transporter
ceiling-saturates at low dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Loop Effects

A

NKCC2
Ascending LOH Na/Cl/K cotransporter
Most effective DOC for acute pulmonary edema with heart failure
Produces a lot of urine
Increases renal blood flow via decreased resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thiazide Effects

A

NKCC2
Site - DCT
Decreases PVR and BP even after volume recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thiazide Indication

A

HTN
Mild heart failure
Hypercalciuria
Diabetes Insipidus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thiazide Urine composition

A

Increased sodium, potassium, Chloride, Magnesium
Decreased Calcium
Increased volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thiazide Adverse effects

A
Give oral only 
NKCC2 
Hypokalemia
Hyponatremia
Hyperuricemia
Volume depletion
**Hyperglycemia**
**Hyperlipidemia**

Takes 1-3 week to obtain stable effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Thiazides

A

Chlorthalidone
Hydrchlorothiazide
Metolazone
(Sulfa derivatives)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Loops

A

Furosemide
Torsemide
Ethacrynic Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aldosterone Agonists

A

Spironolactone

Eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aldosterone Agonist Mechanism

A

Antagonizes aldosterone at cytoplasmic receptors (preventing translocation)
Acts at collecting duct
Used in combination with other diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aldosterone Antagonist Indication

A

Primary hyperaldosteronism

Edema

17
Q

Aldosterone Antagonist PK

A

Oral and strongly protein bound

Induces CYP450

18
Q

Aldosterone Antagonist Adverse Effects

A
GI upset and peptic ulcers
**Endocrine->irregular menstrual cycles, gynecomastia, impotence**
Hyperkalemia
Nausea, Lethargy
Mental Confusion
19
Q

ENaC K sparing Drugs

A

Amiloride

Triamterene

20
Q

ENaC K Sparing Mechanism

A

Blocks Na transport channels
Decreases sodium/potassium exchange
Acts at collecting duct

21
Q

ENaC K sparing indications

A

Primary hyperaldosteronism
Heart failure
Hypokalemia

22
Q

ENaC K sparing Adverse effects

A

Same as spironolactone -GI upset and peptic ulcers, Endocrine issues (gynecomastia, impotence, irregular menstrual), Hyperkalemia, nausea, lethargy, mental confusion
Plus leg cramps**
Increased BUN, uric acid

23
Q

CAH inhibitor Drug

A

Acetazolamide

24
CAH inhibitor Mechanism
Acts mainly in the PT | Prevents formation of H+ needed for Na+ reabsorption in the PT
25
CAH inhibitor Indication
Glaucoma (decreases production of aqueous humor) Treat metabolic alkalosis Mountain sickness prophylaxis Epilepsy
26
CAH inhibitor Adverse effects
**Metabolic acidosis** K depletion (rare) Renal stones **Contraindicated in hepatic cirrhosis due to decreased NH4+ excretion**
27
Osmotic Drug
Mannitol
28
Osmotic Effect
Does not affect sodium excretion
29
Osmotic drug mechanism
Filtered into glomerulus, draws H2O into tubular fluid
30
Osmotic drug indications
Increased ICP Acute renal failure (shock) Drug toxicity Trauma (maintain urine)
31
Osmotic PK
IV only
32
Osmotic Adverse
Extracellular H2O expansion ->Dehydration Hypo or hypernatremia Oral->osmotic diarrhea
33
ADH antagonist
Conivaptan
34
Conivaptan
Inhibits CYP3A4
35
ADH antagonist Effect
Renders CT impermeable to H2O
36
ADH antagonist mechanism
Inhibit ADH | Decrease aquaporins in the collecting duct
37
ADH antagonist indication
SIADH | Hyponatremia
38
ADH antagonist Urine composition
Increased plasma Na | Decreased H2O reabsorption ->dilute urine
39
ADH antagonist PK
IV only
40
ADH antagonist adverse
Nephrogenic diabetes insipidus | Renal failure
41
Diuretic main uses
Management of edema and hypertension